Cellectis SA (CLLS)
3.92
-0.15
(-3.69%)
USD |
NASDAQ |
May 15, 16:00
3.99
+0.07
(+1.79%)
After-Hours: 20:00
Cellectis Market Cap : 394.40M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 1.080B |
| Grifols SA | 5.213B |
| Akari Therapeutics Plc | 3.995M |
| Biodexa Pharmaceuticals Plc | 2.139M |
| NuCana Plc | 9.073M |
Market Cap Related Metrics
| PS Ratio | 5.794 |
| PEG Ratio | -0.5562 |
| Price to Book Value | 6.582 |
| Price | 3.92 |
| Earnings Yield | -17.18% |
| PEGY Ratio | -0.5562 |